Showing results (71-80 of 100) with videos related to
Sort By:
Pageof 10
Frontiers in Immunology|December 5, 2022
Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapiesJessica A Minott, Jacob P van Vloten, Jacob G E Yates, et al.Molecular Therapy. Oncology|December 1, 2025
Oncolytic Newcastle-disease-virus-mediated CD47 blockade in preclinical melanoma and pancreatic cancer modelsJacob G E Yates, Lily Chan, Alyssa E Bogle, et al.Molecular Therapy. Advances|June 3, 2026
Efficient and safe lung gene delivery using AAV6.2FF in neonatal pigs demonstrates pediatric translational potentialNicole Zielinska, Erin L Howard, Cici Yang, et al.Frontiers in Microbiology|February 8, 2024
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancerLisa A Santry, Jacob P van Vloten, Amanda W K AuYeung, et al.Viruses|January 21, 2023
Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 GeneNikesh Tailor, Bryce M Warner, Bryan D Griffin, et al.Cytokine & Growth Factor Reviews|September 7, 2020
Tumour vasculature: Friend or foe of oncolytic viruses?Lisa A Santry, Jacob P van Vloten, Jason P Knapp, et al.Cancers|December 24, 2021
Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of SurvivinRobert C Mould, Jacob P van Vloten, Amanda W K AuYeung, et al.Human Gene Therapy|February 1, 2020
Optimized Pre-Clinical Grade Production of Two Novel Lentiviral Vector Pseudotypes for Lung Gene DeliveryMaría C Rosales Gerpe, Laura P van Lieshout, Jakob M Domm, et al.Gene Therapy|February 2, 2023
Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxisAmira D Rghei, Jacob G E Yates, Jordyn A Lopes, et al.Molecular Therapy Oncolytics|December 11, 2023
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancerJessica A Minott, Jacob P van Vloten, Jake G E Yates, et al.Pageof 10